Risk of Ovarian Hyperstimulation Syndrome in Infertile Patients With PCOS Treated by HP HMG

The study "Risk of ovarian hyperstimulation syndrome in infertile patients with PCOS treated by HP HMG" by Manar Tareq Mohammed, Hamza Elmahaishi, Narges R Ben Halim, and Elmahaishi MS, investigates the risk of ovarian hyperstimulation syndrome (OHSS) in infertile patients with Polycystic Ovary Syndrome (PCOS) who are treated with Highly Purified Human Menopausal Gonadotropin (HP HMG). The study found that the risk of OHSS in these patients is significant, suggesting that careful monitoring and dosage adjustments are necessary when treating PCOS patients with HP HMG to prevent this potentially serious complication. The study, however, does not mention the number of participants involved, which is a crucial factor in determining the strength of the study.